(Total Views: 404)
Posted On: 10/07/2019 11:55:33 AM
Post# of 9144
Re: barniethedino #5222
Barniedinoguy,
I thought you had followed the rest of your dinosaur family into extinction. For you and those of your followers who cannot read I am copying a part of the NanoLogix update from earlier this year. Please note the section where it is CLEARLY STATED that the NIH grant application was submitted by NanoLogix’ Silicon Valley partner. That, to me, somehow indicates that their partner’s name would be on the application/grant, not the name of NanoLogix.
“NanoLogix is pleased to provide this update to our August 2018 statement of coordinated development activity with a California-based Biotechnology firm. The planning for a research study for development of a rapid pre-test for use with the patented Nanologix N-Assay bacteria diagnostic is proceeding, with staff selections completed, letters of recomendation from noted medical authorites written, and the submission last week of the grant application for the study to the NIH by our Silicon-Valley partner. The research study is planned for two major Houston hospitals, funded from both Federal Grants and a raise of investment capital.”
Scott
I thought you had followed the rest of your dinosaur family into extinction. For you and those of your followers who cannot read I am copying a part of the NanoLogix update from earlier this year. Please note the section where it is CLEARLY STATED that the NIH grant application was submitted by NanoLogix’ Silicon Valley partner. That, to me, somehow indicates that their partner’s name would be on the application/grant, not the name of NanoLogix.
“NanoLogix is pleased to provide this update to our August 2018 statement of coordinated development activity with a California-based Biotechnology firm. The planning for a research study for development of a rapid pre-test for use with the patented Nanologix N-Assay bacteria diagnostic is proceeding, with staff selections completed, letters of recomendation from noted medical authorites written, and the submission last week of the grant application for the study to the NIH by our Silicon-Valley partner. The research study is planned for two major Houston hospitals, funded from both Federal Grants and a raise of investment capital.”
Scott
(4)
(1)
